Real-world study shows injectable GLP-1 drugs for obesity have lower weight loss due to treatment discontinuation.

U.S. drug deaths dropped by roughly 40% last year among people under the age of 35. It's a welcome pivot for families and communities devastated by fentanyl.

Pharmaceutical companies are making billions on treatments that can sometimes overpromise and underdeliver for terminal cases.

Microdosing isn’t just popular for psychedelics. Some consumers are taking smaller than standard doses of GLP-1s—the popular class of weight-loss and diabetes drugs that include Ozempic ...

Median annual list price for new drugs over $370,000 in 2024 72% of new drugs in 2024 for orphan diseases Drugmakers emphasize value, offer savings programs amid rising list prices May 22 (Reuters ...

Research on weight loss drugs like Ozempic shows varied results for mental health impacts, with some patients experiencing mood and personality changes.

Weight loss medications are controversial due to some of the side effects caused by the most popular drugs.

The Danish drugmaker, which makes Ozempic and Wegovy, has seen its stock tumble as competition in the weight-loss drug market has grown fiercer.

GLP-1 drugs made a former FDA chief ‘feel ill.’ But he’d take them again. David Kessler has lost more than 60 pounds on weight-loss drugs and believes they can change the trajectory of ...

President Trump will sign an executive order Monday that he says will drop the prices of prescription drugs between 30-80% "almost immediately." ...

Some experts say oral versions of popular weight-loss drugs such as Wegovy could offer people more flexibility and accessibility. What’s keeping the pills from taking off?